The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combination treatment of intratumoral vidutolimod (CMP-001), radiosurgery, nivolumab, and ipilimumab for metastatic colorectal carcinoma.
 
Yaacov Richard Lawrence
Stock and Other Ownership Interests - Protean BioDiagnostics
Consulting or Advisory Role - Roche Pharma AG
Research Funding - Bristol Myers Squibb Foundation; Checkmate Pharmaceuticals
 
Sivan Lieberman
No Relationships to Disclose
 
Ilanit Redinsky
No Relationships to Disclose
 
Nir Honig
No Relationships to Disclose
 
Einat Shacham-Shmueli
No Relationships to Disclose
 
Naama Halpern
No Relationships to Disclose
 
Stephen Raskin
No Relationships to Disclose
 
Damien Urban
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Roche; Takeda
Consulting or Advisory Role - Merck Sharp & Dohme; Nucleai; Rhenium/Oncotest; Roche Israel; Takeda
 
Aliza Ackerstein
No Relationships to Disclose
 
Maoz Ben-Ayun
No Relationships to Disclose
 
Katerina Shulman
No Relationships to Disclose
 
Eitan Ben-Ami
No Relationships to Disclose
 
Valeriya Semenisty
No Relationships to Disclose
 
Ofer Purim
No Relationships to Disclose
 
Nirit Yarom
No Relationships to Disclose
 
Talia Golan
Honoraria - Abbvie; AstraZeneca/MedImmune; MSD
Consulting or Advisory Role - Abbvie; AstraZeneca
Speakers' Bureau - AstraZeneca; MSD Oncology
Research Funding - AstraZeneca (Inst); MSD (Inst)
 
Ben Boursi
No Relationships to Disclose
 
Lina Ziegler
Employment - Bristol Myers Squibb Foundation
 
Art M. Krieg
Employment - Checkmate Pharmaceuticals
Leadership - Checkmate Pharmaceuticals
Stock and Other Ownership Interests - Checkmate Pharmaceuticals
Consulting or Advisory Role - Kernal Biologics; Korro Bio; PepGen; Pfizer; Providence Therapeutics
Patents, Royalties, Other Intellectual Property - patents relating to oligonucleotide technologies and assigned to Checkmate Pharma
 
Ofer Margalit
Employment - Roche
Research Funding - Checkmate Pharmaceuticals
Travel, Accommodations, Expenses - Merck Serono